KYORIN Pharmaceutical Co.,Ltd.'s total assets for Q3 2024 were ¥190.49B, an increase of 6.50% from the previous quarter. JP:4569 total liabilities were ¥60.42B for the fiscal quarter, a 23.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.